Filing Details

Accession Number:
0001209191-21-014736
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-02-26 16:18:21
Reporting Period:
2021-02-24
Accepted Time:
2021-02-26 16:18:21
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
875320 Vertex Pharmaceuticals Inc / Ma VRTX Pharmaceutical Preparations (2834) 043039129
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1661567 Michael Parini C/O Vertex Pharmaceuticals Incorporated
50 Northern Avenue
Boston MA 02210
Evp, Chief Adm, Leg & Bd Off No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2021-02-24 2,416 $217.57 33,865 No 4 F Direct
Common Stock Disposition 2021-02-25 646 $211.58 33,219 No 4 S Direct
Common Stock Disposition 2021-02-25 1,348 $213.04 31,871 No 4 S Direct
Common Stock Disposition 2021-02-25 680 $214.28 31,191 No 4 S Direct
Common Stock Disposition 2021-02-25 354 $216.26 30,837 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 F Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Footnotes
  1. Transaction made pursuant to Mr. Parini's company-approved trading plan under Rule 10b5-1.
  2. Open market sales reported on this line occurred at a weighted average price of $211.58 (range $211.34 to $211.91).
  3. Mr. Parini undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
  4. Open market sales reported on this line occurred at a weighted average price of $213.04 (range $212.76 to $213.68).
  5. Open market sales reported on this line occurred at a weighted average price of $214.28 (range $213.90 to $214.69).
  6. Open market sales reported on this line occurred at a weighted average price of $216.26 (range $215.79 to $216.76).